Moreover, the SLE B cell abnormality extended to increased expression of PTPs, globally enhanced PTP and PSP activities, and maximal constitutive recruitment of the PTP SHP-1 to CD22. This evidence concerns the gene CD22 and systemic lupus erythematosus.